- Kivisto K.T.
- Kroemer H.K.
- Eichelbaum M.
The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.Br J Clin Pharmacol. 1995; 40: 523-530
Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles.Drug Metab Dispos. 1999; 27: 655-666
Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer.Cancer Gene Ther. 2001; 8: 473-482
Clinical relevance of genetic polymorphisms in the human CYP2C subfamily.Br J Clin Pharmacol. 2001; 52: 349-355
Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.Drug Metab Rev. 1997; 29: 413-580
The role of C-reactive protein as a prognostic indicator in advanced cancer.Curr Oncol Rep. 2002; 4: 250-255
Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer.Cytokine. 1999; 11: 80-86
- Barber M.D.
- Fearon K.C.
- Ross J.A.
Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.Clin Sci (Lond). 1999; 96: 83-87
Acute phase proteins in patients with large and locally advanced breast cancer treated with neo-adjuvant chemotherapy: response and survival.Int J Oncol. 1998; 13: 589-594
Inflammation and cancer.Nature. 2002; 420: 860-867
Regulation of cytochromes P450 during inflammation and infection.Drug Metab Rev. 1997; 29: 1129-1188
- Roy-Chowdhury J.
- Locker J.
- Roy-Chowdhury N.
Nuclear receptors orchestrate detoxification pathways.Dev Cell. 2003; 4: 607-608
Inflammation and cancer: back to Virchow?.Lancet. 2001; 357: 539-545
Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression.J Immunother. 1999; 22: 25-32
- Kinoshita T.
- Ito H.
- Miki C.
Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma.Cancer. 1999; 85: 2526-2531
The role of human papillomaviruses in human cancers.Front Biosci. 2002; 7: d641-d649
Pathogenesis of Helicobacter pylori infection.Helicobacter. 2002; 7: 17-23
Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus.Vaccine. 2003; 21: 4626-4649
- Rosin M.P.
- Anwar W.A.
- Ward A.J.
Inflammation, chromosomal instability, and cancer: the schistosomiasis model.Cancer Res. 1994; 54: 1929s-1933s
- Manning C.B.
- Vallyathan V.
- Mossman B.T.
Diseases caused by asbestos: mechanisms of injury and disease development.Int Immunopharmacol. 2002; 2: 191-200
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status.Int J Cancer. 2002; 98: 84-91
Acute-phase proteins and other systemic responses to inflammation.N Engl J Med. 1999; 340: 448-454
Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6.Hepatology. 1990; 12: 1179-1186
Chronic inflammation as inductor of pro-cancer microenvironment: pathogenesis of dysregulated feedback control.Cancer Metast Rev. 2003; 22: 95-102
- Slaviero K.A.
- Clarke S.J.
- Rivory L.P.
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy.Lancet Oncol. 2003; 4: 224-232
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.N Engl J Med. 1997; 336: 1066-1071
- Ghosh S.
- May M.J.
- Kopp E.B.
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.Annu Rev Immunol. 1998; 16: 225-260
Missing pieces in the NF-kappaB puzzle.Cell. 2002; : S81-S96
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.Annu Rev Immunol. 2000; 18: 621-663
The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.J Exp Med. 1999; 189: 1839-1845
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.Science. 2001; 293: 1495-1499
The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways.Immunity. 2002; 17: 525-535
- Ben-Neriah Y.
- Schmitz M.L.
Of mice and men.EMBO Rep. 2004; 5: 668-673
The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.Nat Med. 2003; 9: 575-581
NF-kappaB in cancer: from innocent bystander to major culprit.Nat Rev Cancer. 2002; 2: 301-310
Is NF-kappaB2/p100 a direct activator of programmed cell death?.Cancer Cell. 2002; 2: 431-433
The Rel/NF-kappaB signal transduction pathway: introduction.Oncogene. 1999; 18: 6842-6844
Deregulation of NF-kappaB and its upstream kinases in cancer.Cancer Metast Rev. 2003; 22: 405-422
NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach.Semin Cancer Biol. 2003; 13: 15-28
NF-kappaB at the crossroads of life and death.Nat Immunol. 2002; 3: 221-227
- Balkwill F.
- Coussens L.M.
Cancer: an inflammatory link.Nature. 2004; 431: 405-406
NF-kappaB functions as a tumour promoter in inflammation-associated cancer.Nature. 2004; 431: 461-466
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.Cell. 2004; 118: 285-296
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.Gastroenterology. 1998; 115: 357-369
Nuclear factor-kappa B is upregulated in colorectal cancer.Surgery. 2001; 130: 363-369
Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis.Oncology. 2003; 65: 37-45
Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer.Int J Colorectal Dis. 2004; 19: 18-22
Molecular viral oncology of hepatocellular carcinoma.Oncogene. 2003; 22: 5093-5107
- Dogra S.C.
- Khanduja K.L.
- Sharma R.R.
Hepatic drug-metabolizing enzymes in lung tumor-bearing rats.Biochem Pharmacol. 1985; 34: 3190-3193
- Maliakal P.P.
- Coville P.F.
- Wanwimolruk S.
Decreased hepatic drug metabolising enzyme activity in rats with nitrosamine-induced tumours.Drug Metabol Drug Interact. 2002; 19: 13-27
Expression of xenobiotic-metabolizing enzymes by primary and secondary hepatic tumors in man.Int J Radiat Oncol Biol Phys. 1994; 29: 277-283
CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes.Br J Cancer. 2004; 90: 911-916
Characterization of cytochrome P450 expression in human oesophageal mucosa.Carcinogenesis. 1999; 20: 243-248
Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems.Cancer Res. 1992; 52: 6567-6575
Expression of cytochromes P450 in human breast tissue and tumors.Drug Metab Dispos. 1996; 24: 899-905
- Rivory L.P.
- Slaviero K.A.
- Clarke S.J.
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response.Br J Cancer. 2002; 87: 277-280
Factors affecting cytochrome P-450 3A activity in cancer patients.Clin Cancer Res. 2004; 10: 8341-8350
Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics.Clin Pharmacol Ther. 1994; 55: 649-660
Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.J Biol Chem. 2000; 275: 15122-15127
Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification.Mol Pharmacol. 2002; 62: 638-646
Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes.Biochem Biophys Res Commun. 2000; 274: 707-713
Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response.Biochem Biophys Res Commun. 2002; 293: 145-149
- Teng S.
- Piquette-Miller M.
The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice.J Pharmacol Exp Ther. 2005; 312: 841-848
Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators.Mol Pharmacol. 2000; 58: 361-372
Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation.Mol Pharmacol. 2000; 58: 1441-1450
Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor.Eur J Biochem. 2001; 268: 6346-6358
- Beato M.
- Herrlich P.
- Schutz G.
Steroid hormone receptors: many actors in search of a plot.Cell. 1995; 83: 851-857
Glucocorticoid-regulated transcription factors.Pulm Pharmacol Ther. 2001; 14: 211-219
Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element.Mol Endocrinol. 2003; 17: 42-55
Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance.Hepatology. 2004; 40: 951-960
Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.Mol Cell Biol. 1995; 15: 943-953
I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor.EMBO J. 1997; 16: 4698-4707
- Nissen R.M.
- Yamamoto K.R.
The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.Genes Dev. 2000; 14: 2314-2329
p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex.J Biol Chem. 2001; 276: 30208-30215
Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptor.FASEB J. 2001; 15: 2030-2032
Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.Oncogene. 2003; 22: 3279-3287
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor.EMBO J. 2001; 20: 7168-7173
The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin.J Cell Biol. 1999; 147: 1365-1370
Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1.J Biol Chem. 1998; 273: 29291-29294
Clinical update: proteasome inhibitors in hematologic malignancies.Cancer Treat Rev. 2003; 29: 33-39
- Milligan S.A.
- Nopajaroonsri C.
Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro.Anticancer Res. 2001; 21: 39-44
- Karin M.
- Yamamoto Y.
- Wang Q.M.
The IKK NF-kappa B system: a treasure trove for drug development.Nat Rev Drug Discov. 2004; 3: 17-26
Colorectal cancer prevention in ulcerative colitis: a case-control study.Aliment Pharmacol Ther. 2000; 14: 145-153
Inhibition of NF-kappa B by sodium salicylate and aspirin.Science. 1994; 265: 956-959
- Yin M.J.
- Yamamoto Y.
- Gaynor R.B.
The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.Nature. 1998; 396: 77-80
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.Nat Rev Cancer. 2001; 1: 11-21
- Shishodia S.
- Koul D.
- Aggarwal B.B.
Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.J Immunol. 2004; 173: 2011-2022
Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB.Proc Natl Acad Sci USA. 1998; 95: 2307-2312
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.Cancer Res. 1998; 58: 1408-1416
Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.Cancer Res. 2000; 60: 3761-3769
NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells.J Biol Chem. 1997; 272: 15174-15183
NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells.Oncogene. 2003; 22: 90-97
Tumoral drug metabolism: overview and its implications for cancer therapy.J Clin Oncol. 2005; 23: 205-229